Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial
Go back to Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial| (NASDAQ: ELDN) | Delayed: 2.62 -0.03 (1.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.65 | 52 Week High | $ | |||
| Open | $2.67 | 52 Week Low | $ | |||
| Day High | $2.68 | P/E | N/A | |||
| Day Low | $2.57 | EPS | $ | |||
| Volume | 828,838 | |||||
| (NASDAQ: NTRA) | Delayed: 369.39 +3.08 (0.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $366.31 | 52 Week High | $13.80 | |||
| Open | $365.78 | 52 Week Low | $6.52 | |||
| Day High | $369.69 | P/E | N/A | |||
| Day Low | $358.90 | EPS | $0.00 | |||
| Volume | 3,718,175 | |||||
